-
Register
- User - $27.50
Nurse practitioners are uniquely positioned, but may be inadequately prepared to recognize or respond to a person being victimized by a trafficker. The International Labor Organization estimates there are up to 40.3 million victims of human trafficking worldwide. In the U.S. these forms of exploitation usually encompass sex and labor trafficking. However, globally, this $150 billion industry encompasses additional forms of trafficking include organ trafficking, child soldiering and child marriage. This course is designed to equip NPs and other health care professionals to recognize, educate and appropriately respond to patients who may be victimized by traffickers.
Credits: 1.0 Contact Hours; 0 are Pharmacology
Expiration Date: December 31, 2024
$27.50
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-the role of the healthcare provider in prevention, differential diagnosis, identification, referral, treatment, aftercare, and advocacy for trafficking victims
-the impacts of COVID-19 on victim exploitation and abuse
-emerging trends and disparities in diverse care environments with effective response across the health care continuum
Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP
Clinical Professor
Baylor University
Dr. Jessica Peck is an expert pediatric clinician and anti-trafficking advocate who provides innovative, visionary, and award-winning leadership to develop and lead inclusive and diverse inter-professional teams in multiple arenas to provide outcomes of high-quality health care.
Dr. Peck is a recognized and published national expert about human trafficking. She served as founding Chair of the Alliance for Children in Trafficking, a national campaign of the National Association of Pediatric Nurse Practitioners Partners for Vulnerable Youth, where she worked with other national organizations to equip healthcare professionals to combat human trafficking of children and advocates for other vulnerable youth populations. Dr. Peck worked with the Office of Trafficking in Persons to help create a set of core competencies for health care professionals caring for trafficked individuals. She serves as the Lead Medical Consultant for UnBound Houston and helped to create a statewide continuing education and to pass legislation mandating CE for all direct care providers in Texas.
Dr. Peck is currently a Professor of Nursing at Baylor University in Dallas, Texas. She holds active credentials as a Pediatric Nurse Practitioner, a Certified Nurse Educator, and a Clinical Nurse Leader. Dr. Peck has been practicing as a Pediatric Nurse Practitioner for more than 15 years in primary care environments. Dr. Peck travels nationally to speak on the use of technology in nursing education and practice, including health impacts of social media use by teens. As both a nurse practitioner and a mother of four children, she has a special interest in educating and equipping families to promote positive physical, emotional, mental, social and spiritual health. She regularly writes articles for parenting magazines and is a frequent guest on radio and television to promote the health of children.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN has disclosed:
Sequirus Consultant: Pediatrics Flucelvax
MD Briefcase Consultant: Pediatric COVID vaccine
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
